| Ident. | Authors (with country if any) | Title |
|---|
| 002629 (2007) |
M. D. Norenberg [États-Unis] ; K. V. Rama Rao [États-Unis] | The mitochondrial permeability transition in neurologic disease |
| 002919 (2006) |
Judith Miklossy [Canada] ; Tetsuaki Arai [Japon] ; Jian-Ping Guo [Canada] ; Andis Klegeris [Canada] ; SHENG YU [Canada] ; Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | LRRK2 expression in normal and pathologic human brain and in human cell lines |
| 002921 (2006) |
Catherine L. Burton [Canada] ; Esther Strauss [Canada] ; David F. Hultsch [Canada] ; Alex Moll [Canada] ; Michael A. Hunter [Canada] | Intraindividual variability as a marker of neurological dysfunction : A comparison of Alzheimer's disease and Parkinson's disease |
| 002934 (2006) |
Richard Camicioli [Canada] ; Thomas Bouchard [Canada] ; Lisa Licis [Canada] | Dual-tasks and walking fast : Relationship to extra-pyramidal signs in advanced Alzheimer disease |
| 002945 (2006) |
Alan S. Hazell [Canada] ; Louise Normandin [Canada] ; Michael D. Norenberg [États-Unis] ; Gregory Kennedy [Canada] ; Jae-Hyuk Yi [Canada] | Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment |
| 002A70 (2005) |
Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Chymotrypsin‐like proteases contribute to human monocytic THP‐1 cell as well as human microglial neurotoxicity |
| 002B20 (2005) |
Edith G. Mcgeer [Canada] ; Andis Klegeris [Canada] ; Patrick L. Mcgeer [Canada] | Inflammation, the complement system and the diseases of aging |
| 002D19 (2004) |
Richard Camicioli [Canada] ; Lisa Licis [Canada] | Motor impairment predicts falls in specialized Alzheimer care units |
| 002F12 (2003) |
Sophie Vigouroux [France] ; Yoshiaki Furukawa [Canada] ; Luc Farout [France] ; Stephen J. Kish [Canada] ; Marièle Briand [France] ; Yves Briand [France] | Peptidase activities of the 20/26S proteasome and a novel protease in human brain |
| 002F36 (2003) |
Bhagu R. Bhavnani [Canada] | Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's |
| 002F39 (2003) |
Benoit Melchior [France] ; Véronique Nerriere-Daguin [France] ; David-A. Laplaud [France] ; Séverine Remy [France] ; Sandrine Wiertlewski [France] ; Isabelle Neveu [France] ; Philippe Naveilhan [France] ; Susan O. Meakin [Canada] ; Philippe Brachet [France] | Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection |
| 003054 (2002) |
H. Uri Saragovi [Canada] ; Maria Clara Zaccaro [Canada] | Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites |
| 003060 (2002) |
Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada] | Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases |
| 003306 (2001) |
Evian Gordon [Australie] | Integrative psychophysiology |
| 003533 (2000) |
C. Schwab [Canada] ; P. L. Mcgeer [Canada] | Aβ42-Carboxy-Terminal-like Immunoreactivity Is Associated with Intracellular Neurofibrillary Tangles and Pick Bodies |
| 003547 (2000) |
E. B. Mukaetova-Ladinska [États-Unis] ; J. Hurt [États-Unis] ; R. Jakes [États-Unis] ; J. Xuereb [États-Unis, Royaume-Uni] ; W. G. Honer [Canada] ; C. M. Wischik [Royaume-Uni] | α-Synuclein inclusions in Alzheimer and Lewy body diseases |
| 003555 (2000) |
S. L. Mitchell [États-Unis] ; K. Rockwood [Canada] | The association between parkinsonism, Alzheimer's disease, and mortality: A comprehensive approach |
| 003588 (2000) |
M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS |
| 003789 (1999) |
M. Panisset [Canada] | Syndromes extra-pyramidaux chez la personnes âgées |
| 003928 (1998) |
C. Schwab [Canada] ; P. L Mcgeer [Canada] | Tubulin Immunopositive Structures Resembling Intracellular Neurofibrillary Tangles |
| 003A33 (1998) |
C. F. Lippa [États-Unis] ; H. Fujiwara [Japon] ; D. M. A. Mann [Royaume-Uni] ; B. Giasson [États-Unis] ; M. Baba [Japon] ; M. L. Schmidt [États-Unis] ; L. E. Nee [États-Unis] ; B. O'Connell [États-Unis] ; D. A. Pollen [États-Unis] ; P. S. George-Hyslop [Canada] ; B. Ghetti [États-Unis] ; D. Nochlin [États-Unis] ; T. D. Bird [États-Unis] ; N. J. Cairns [Royaume-Uni] ; V. M.-Y. Lee [États-Unis] ; T. Iwatsubo [Japon] ; J. Q. Trojanowski [États-Unis] | Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes |
| 003A40 (1998) |
P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] | Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions |
| 003A43 (1998) |
C. Schwab [Canada] ; H. Akiyama [Japon] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of β-amyloid protein |
| 003A47 (1998) |
C. A. Shaw [Canada] ; J. S. Bains [Canada] | Did consumption of flour bleached by the agene process contribute to the incidence of neurological disease? |
| 003A53 (1998) |
D. P. Perl [États-Unis] ; C. W. Olanow [États-Unis] ; D. Calne [Canada] | Alzheimer's disease and Parkinson's disease : Distinct entities or extremes of a spectrum of neurodegeneration? |
| 003A56 (1998) |
A. Takeda [États-Unis, Japon] ; M. Mallory [États-Unis] ; M. Sundsmo [États-Unis] ; W. Honer [Canada] ; L. Hansen [États-Unis] ; E. Masliah [États-Unis] | Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders |
| 003B06 (1997) |
Jaswinder S. Bains [Canada] ; Christopher A. Shaw [Canada] | Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death |
| 003C45 (1997) |
P. Caffarra [Italie] ; L. Riggio [Italie] ; L. Malvezzi [Italie] ; A. Scaglioni [Italie] ; M. Freedman [États-Unis, Canada] | Orienting of visual attention in Alzheimer's disease : Its implication in favor of the interhemispheric balance |
| 003C49 (1997) |
M. Mamelak [Canada] | Neurodegeneration, sleep, and cerebral energy metabolism : A testable hypothesis |
| 003C71 (1997) |
M. Freedman [Canada] ; M. Oscar-Berman [États-Unis] | Breakdown of cross-modal function in dementia |
| 003C72 (1997) |
C. Schwab [Canada] ; J. C. Steele [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles |
| 003E58 (1996) |
Claudia Schwab [États-Unis] ; John C. Steele ; Haruhiko Akiyama ; Patrick L. Mcgeer [États-Unis] | Distinct distribution of apolipoprotein E and β-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam |
| 003E84 (1996) |
J. E. Graham [Canada] ; A. B. Mitnitski [Canada] ; A. J. Mogilner ; D. Gauvreau [Canada] ; K. Rockwood [Canada] | Symptoms and signs in dementia : Synergy and antagonism |
| 003F04 (1996) |
L. D. Morrison [Canada] ; D. D. Smith [Canada] ; S. J. Kish [Canada] | Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease |
| 004098 (1995) |
P. Chagnon [Canada] ; C. Betard ; Y. Robitaille ; A. Cholette ; D. Gauvreau | Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases |
| 004099 (1995) |
E. Mohr [Canada] ; P. Brouwers ; J. J. Claus ; S. E. Purdon [Canada] ; M. Gagnon [Canada] ; T. N. Chase | Differential classification of dementia |
| 004105 (1995) |
M.-G. Martinoli [Canada] ; J. Q. Trojanowski ; M. L. Schmidt ; S. E. Arnold ; T. M. Fujiwara ; V. M.-Y. Lee ; H. Hurtig ; J.-P. Julien [Canada] ; C. Clark | Association of apolipoprotein ε4 allele and neuropathologic findings in patients with dementia |
| 004159 (1994) |
Peter H. Yu [Canada] | Pharmacological and clinical implications of MAO-B inhibitors |
| 004289 (1994) |
M. C. Tierney [Canada] ; A. Nores ; W. G. Snow ; R. H. Fisher ; M. L. Zorzitto ; D. W. Reid | Use of the Rey Auditory Verbal Learning Test in differentiating normal aging from Alzheimer's and Parkinson's dementia |
| 004301 (1994) |
O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. Mcgeer | Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases |
| 004306 (1994) |
M. Huberman [Canada] ; M. Moscovitch ; M. Freedman [Canada] | Comparison of patients with Alzheimer's and Parkinson's disease on different explicit and implicit tests of memory |
| 004401 (1993) |
B. J. Snow [Canada] ; I. Tooyama [Canada, Japon] ; I. Mcgeer [Canada] ; T. Yamada [Canada] ; D. B. Calne [Canada] ; H. Takahashi [Canada] ; H. Kimura [Japon] | Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels |
| 004429 (1993) |
A. H. Rajput [Canada] ; B. Rozdilsky [Canada] ; Alex Rajput [Canada] | Alzheimer's Disease and Idiopathic Parkinson's Disease Coexistence |
| 004438 (1993) |
M. S. Pollanen [Canada] ; D. W. Dickson ; C. Bergeron | Pathology and biology of the Lewy body |
| 004460 (1993) |
R. Quirion [Canada] | Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release |
| 004461 (1993) |
A. P. Sen [Canada] ; P. Boksa ; R. Quirion | Brain calcium channel related dihydropyridine and phenylalkylamine binding sites in Alzheimer's, Parkinson's and Huntington's diseases |
| 004462 (1993) |
K. Mizukawa [Canada] ; E. G. Mcgeer ; P. L. Mcgeer | Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, alzheimer disease, and neurologically normal controls |
| 004656 (1992) |
I. Aubert [Canada] ; D. M. Araujo ; D. Cecyre ; Y. Robitaille ; S. Gauthier ; R. Quirion | Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases |
| 004659 (1992) |
E. G. Mcgeer [Canada] ; E. A. Singh | Angiotensin-converting enzyme in cortisal tissue in Alzheimer's and some other neurological diseases |
| 004817 (1991) |
J. A. Jesberger ; J. S. Richardson | Oxygen free radicals and brain dysfunction |
| 004819 (1991) |
D. B. Calne [Canada] | Neurotoxins and degeneration in the central nervous system |
